Delivery Order SPE2DB22D1106-SPE2DB24FEXG5
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $11,804.40 firm fixed-price delivery order is for the supply of CABENUVA ER 600 MG-900 MG SUSP 6ML, a specialty medication, with a performance period through December 11, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which serves as a primary vehicle...
- This contract award to AmerisourceBergen Drug Corp is a delivery order contract (SPE2DX15D1022|SPE2DX24FVNAF) with the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, for the supply of CABENUVA ER 600 MG-900 MG SUSP 6ML, a pharmaceutical product. The contract has a ceiling value of $30,426.80 and an ultimate completion date of October 1, 2024. This award is not set aside. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $10,562.45 on December 11, 2025, for CABENUVA ER 600 MG-900 MG suspension (6 mL). This is a firm fixed-price, competitively awarded contract with no set-aside designation, with performance scheduled to conclude by January 5, 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 27, 2025, for the supply of CABENUVA ER 600 MG-900 MG suspension in 6 mL quantities, valued at $38,169.00 under a firm fixed-price arrangement. This non-competitive set-aside delivery order will be performed in Conshohocken, Pennsylvania, with an ultimate completion date of October 20, 2025. The award represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 22, 2025, for the supply of Cabenuva ER 600 mg-900 mg suspension (6 mL) with a ceiling value of $40,224.30 and a firm fixed price contract type. This delivery order is non-set-aside and will be completed by January 14, 2026, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's...
- This federal contract award, valued at $7,606.72, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, Corporate Office Division. The contract is for the delivery of CABENUVA ER 600 MG-900 MG SUSP 6ML, a pharmaceutical product, with a completion date of September 19, 2024. This is a firm fixed-price delivery order contract, and there is no set-aside designation. AmerisourceBergen, one of the largest pharmaceutical distributors in the United States, has been awarded...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) to provide a wide range of pharmaceutical products and medical supplies. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which runs through November 2026. The IDC serves as the primary vehicle for Amerisourcebergen to deliver essential medical commodities, including specialty medications,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $783,305.47 and is for the delivery of a variety of pharmaceutical products and medical supplies, including medications across multiple therapeutic domains such as diabetes, neurology, pain management, and antibiotics. The delivery order is not designated as a set-aside and is part of a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under a large Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The contract, which runs through November 2026, provides a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The award covers a wide variety of...
- This federal contract award, with a ceiling value of $33,564.31, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which runs through November 2026 and serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FEXG5Delivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CABENUVA ER 600 MG-900 MG SUSP 6ML, a pharmaceutical product, with a ceiling value of $3,803.35. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This particular contract award does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 6/14/24 |